296 related articles for article (PubMed ID: 26058757)
1. The association between breast cancer and thyroid cancer: a meta-analysis.
Joseph KR; Edirimanne S; Eslick GD
Breast Cancer Res Treat; 2015 Jul; 152(1):173-181. PubMed ID: 26058757
[TBL] [Abstract][Full Text] [Related]
2. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients.
Grantzau T; Overgaard J
Radiother Oncol; 2016 Dec; 121(3):402-413. PubMed ID: 27639892
[TBL] [Abstract][Full Text] [Related]
3. The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis.
Nielsen SM; White MG; Hong S; Aschebrook-Kilfoy B; Kaplan EL; Angelos P; Kulkarni SA; Olopade OI; Grogan RH
Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):231-8. PubMed ID: 26908594
[TBL] [Abstract][Full Text] [Related]
4. Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis.
Subramanian S; Goldstein DP; Parlea L; Thabane L; Ezzat S; Ibrahim-Zada I; Straus S; Brierley JD; Tsang RW; Gafni A; Rotstein L; Sawka AM
Thyroid; 2007 Dec; 17(12):1277-88. PubMed ID: 18020916
[TBL] [Abstract][Full Text] [Related]
5. Risk of second primary malignancies in women with papillary thyroid cancer.
Canchola AJ; Horn-Ross PL; Purdie DM
Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
[TBL] [Abstract][Full Text] [Related]
6. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
7. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L
Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430
[TBL] [Abstract][Full Text] [Related]
8. Association of thyroid, breast and renal cell cancer: a population-based study of the prevalence of second malignancies.
Van Fossen VL; Wilhelm SM; Eaton JL; McHenry CR
Ann Surg Oncol; 2013 Apr; 20(4):1341-7. PubMed ID: 23263698
[TBL] [Abstract][Full Text] [Related]
9. The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer.
Verkooijen RB; Smit JW; Romijn JA; Stokkel MP
Eur J Endocrinol; 2006 Dec; 155(6):801-6. PubMed ID: 17132748
[TBL] [Abstract][Full Text] [Related]
10. Nonendocrine cancers associated with benign and malignant parathyroid tumors.
Fallah M; Kharazmi E; Sundquist J; Hemminki K
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1108-14. PubMed ID: 21525164
[TBL] [Abstract][Full Text] [Related]
11. Thyroid cancer as second primary malignancy in breast cancer patients.
Sioka C; Fotopoulos A
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1604; author reply 1604. PubMed ID: 19306760
[No Abstract] [Full Text] [Related]
12. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP
Thyroid; 2009 May; 19(5):451-7. PubMed ID: 19281429
[TBL] [Abstract][Full Text] [Related]
13. Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review.
Nandy N; Dasanu CA
Curr Med Res Opin; 2013 Sep; 29(9):1055-65. PubMed ID: 23777310
[TBL] [Abstract][Full Text] [Related]
14. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001.
Soerjomataram I; Louwman WJ; de Vries E; Lemmens VE; Klokman WJ; Coebergh JW
Breast Cancer Res Treat; 2005 Sep; 93(1):91-5. PubMed ID: 16184464
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer in thyroid cancer survivors: An analysis of the Surveillance, Epidemiology, and End Results-9 database.
Kuo JH; Chabot JA; Lee JA
Surgery; 2016 Jan; 159(1):23-9. PubMed ID: 26522696
[TBL] [Abstract][Full Text] [Related]
16. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
Grundmann RT; Meyer F
Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
[TBL] [Abstract][Full Text] [Related]
17. Second primary malignancies following thyroid cancer: a population-based study in Taiwan.
Lu CH; Lee KD; Chen PT; Chen CC; Kuan FC; Huang CE; Chen MF; Chen MC
Eur J Endocrinol; 2013 Nov; 169(5):577-85. PubMed ID: 23939917
[TBL] [Abstract][Full Text] [Related]
18. Incidence of second primary malignancies in patients with thyroid cancer in the Turkish population.
Karaköse M; Çordan İ; Can M; Kocabaş M; Kulaksızoğlu M; Karakurt F
Turk J Med Sci; 2019 Oct; 49(5):1529-1533. PubMed ID: 31651125
[TBL] [Abstract][Full Text] [Related]
19. Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer.
Consorti F; Di Tanna G; Milazzo F; Antonaci A
World J Surg Oncol; 2011 Aug; 9():88. PubMed ID: 21835042
[TBL] [Abstract][Full Text] [Related]
20. Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis.
Molina-Montes E; Requena M; Sánchez-Cantalejo E; Fernández MF; Arroyo-Morales M; Espín J; Arrebola JP; Sánchez MJ
Gynecol Oncol; 2015 Jan; 136(1):158-71. PubMed ID: 25448459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
